AVVH.US AVVAA World Health Care Products Inc
- Market cap
- USD 3.19M
- P/E
- -
- P/B
- -
- ROE
- -22.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.
Is AVVH.US undervalued?
Graham numberThe Graham number of AVVAA World Health Care Products Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AVVAA World Health Care Products Inc fundamental analysis
No fundamental analysis for AVVAA World Health Care Products Inc yet.
AVVAA World Health Care Products Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AVVAA World Health Care Products Inc
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which…
Full company profileAVVAA World Health Care Products Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
AVVAA World Health Care Products Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.08K | 36.6K | 6.62K | 13.5K | 32.7K | - | 2.00K | - | 4.65K | 158K | 189K |
| Gross Profit | 226.00 | 26.0K | 3.51K | 12.8K | 31.1K | - | -7.76K | - | 1.52K | 52.5K | 81.3K |
| Operating Income | -635K | -583K | -428K | -41.4K | 24.5K | -29.0K | -75.3K | -42.8K | -34.7K | 4.77K | 10.4K |
| EBITDA | - | - | -428K | -41.4K | 24.5K | -29.0K | -75.3K | -42.8K | -34.7K | 4.77K | 10.4K |
| Net Income | 861K | 2.72M | 2.21M | -41.4K | 24.5K | -29.0K | -75.3K | -42.8K | -39.1K | -18.5K | -25.7K |
| EPS | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 31.6K | 46.7K | 14.6K | 431.00 | 103K | 273K | - | - | 243K | 1.65M | 1.51M |
| Total Liabilities | 21.8M | 15.4M | 13.1M | 13.1M | 13.1M | 90.6K | - | - | 284K | 1.53M | 1.39M |
| Shareholders' Equity | -21.8M | -15.4M | -13.1M | -13.1M | -13.0M | 182K | - | - | -41.1K | 120K | 114K |
| Cash & Short-term Investments | 4.27K | 31.9K | 408.00 | 649.00 | 244.00 | 127K | - | - | 11.8K | 24.1K | 97.0K |
| Total Debt | - | - | 5.46M | 5.46M | 5.46M | - | - | - | 250K | 1.48M | 1.35M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.01K | -210K | -119K | 242.00 | 79.0K | - | - | - | -246K | 32.7K | 820K |
| Capital Expenditure | 0.00 | 0.00 | 75.5K | 75.5K | 3.00 | - | - | - | 0.00 | 4.00 | 0.00 |
| Free Cash Flow | - | - | -119K | - | 79.0K | - | - | - | -246K | 32.7K | 820K |
| Ratios | |||||||||||
| ROE | - | - | - | - | - | -15.9% | - | - | - | -15.4% | -22.6% |
| ROA | 2,719.7% | 5,826.2% | 15,197.0% | -9,613.0% | 23.8% | -10.6% | - | - | -16.1% | -1.1% | -1.7% |
| Net Profit Margin | 41,417.1% | 7,436.2% | 33,436.2% | -307.1% | 75.0% | - | -3,762.9% | - | -841.4% | -11.7% | -13.6% |
| Debt to Equity | - | - | - | - | - | - | - | - | - | 12.29x | 11.83x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
AVVAA World Health Care Products Inc dividends
AVVAA World Health Care Products Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:100 on Jun 5, 2008.
Who owns AVVAA World Health Care Products Inc
Ownership data of AVVAA World Health Care Products Inc is not available yet.
AVVAA World Health Care Products Inc company profile
- Company name
- AVVAA World Health Care Products Inc
- Ticker
- AVVH.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Capital Markets
- Employees
- 5
- Fiscal year end
- May
- Address
- 7400 Beaufont Springs Drive, Richmond, VA, United States, 23225
- Phone
- 866 864 6598
- Website
- avvaaworldhealth.com
About AVVAA World Health Care Products Inc
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.
AVVAA World Health Care Products Inc management
2- Mr. Jason PriceCEO, COO & Director
- Dr. Stephanie WilletInterim President, Treasurer, Secretary & Director